Cara Therapeutics, Inc. (CARA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 20.36M |
| Enterprise value | -42.37M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.19 |
| Price/book (mrq) | 0.68 |
| Enterprise value/revenue | 4.83 |
| Enterprise value/EBITDA | -2.32 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.69 |
| 52-week change 3 | -88.83% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 3.4500 |
| 52-week low 3 | 0.2400 |
| 50-day moving average 3 | 0.4691 |
| 200-day moving average 3 | 0.7764 |
Share statistics
| Avg vol (3-month) 3 | 897.8k |
| Avg vol (10-day) 3 | 628.73k |
| Shares outstanding 5 | 54.68M |
| Implied shares outstanding 6 | 54.68M |
| Float 8 | 46.62M |
| % held by insiders 1 | 15.25% |
| % held by institutions 1 | 40.49% |
| Shares short (15 Jul 2024) 4 | 613.35k |
| Short ratio (15 Jul 2024) 4 | 0.33 |
| Short % of float (15 Jul 2024) 4 | 1.30% |
| Short % of shares outstanding (15 Jul 2024) 4 | 1.12% |
| Shares short (prior month 14 Jun 2024) 4 | 2.27M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,277.05% |
Management effectiveness
| Return on assets (ttm) | -62.20% |
| Return on equity (ttm) | -147.29% |
Income statement
| Revenue (ttm) | 16.94M |
| Revenue per share (ttm) | 0.31 |
| Quarterly revenue growth (yoy) | -65.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -120.87M |
| Net income avi to common (ttm) | -122.54M |
| Diluted EPS (ttm) | -2.2600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 69.77M |
| Total cash per share (mrq) | 1.28 |
| Total debt (mrq) | 7.04M |
| Total debt/equity (mrq) | 23.64% |
| Current ratio (mrq) | 5.38 |
| Book value per share (mrq) | 0.55 |
Cash flow statement
| Operating cash flow (ttm) | -87.91M |
| Levered free cash flow (ttm) | -49.98M |
© 2024 Yahoo. All rights reserved.